Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort
Journal article published in 2018 by
Marc Puigvehí 
,
Beatriz De Cuenca,
Ana Viu,
Moisés Diago,
Juan Turnes,
Francisco Gea,
Juan M. Pascasio,
Sabela Lens ,
Joaquín Cabezas ,
Ester Badia,
Antonio Olveira,
Rosa M. Morillas,
Xavier Torras,
Silvia Montoliu,
Patricia Cordero
and other authors.
,
Beatriz De Cuenca,
Ana Viu,
Moisés Diago,
Juan Turnes,
Francisco Gea,
Juan M. Pascasio,
Sabela Lens ,
Joaquín Cabezas ,
Ester Badia,
Antonio Olveira,
Rosa M. Morillas,
Xavier Torras,
Silvia Montoliu,
Patricia Cordero
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 